Acute promyelocytic leukaemia is characterized by translocations that involve the retinoic acid receptor a (RARa) locus on chromosome 17 and the PML locus on 15 or the PLZF locus on 11. The resulting abnormal translocation products encode for PML/ RARa or PLZF/RARa fusion proteins. There is increasing experimental evidence that the APL-speci®c fusion proteins have similar biologic activities on dierentiation and survival and that both components of the fusion proteins (PML or PLZF and RARa) are indispensable for these biological activities. The physiologic function of PML or PLZF or whether PML and PLZF contribute common structural or functional features to the corresponding fusion proteins is not known. We report here immuno¯uorescence studies on the cellular localization of PLZF and PLZF/RARa and compare it with the localization of PML and PML/RARa. PLZF localizes to nuclear domains of 0.3-0.5 microns, approximately 14 per cell in the KG1 myeloid cell line. These PLZF-bodies are morphologically similar to the domains reported for PML (PML-NBs). There is tight spatial relationship between about 30% of PLZ-NBs and PML-NBs: they partially overlap. However, PML and PLZF do not form soluble complexes in vivo. PLZF-and PML-NBs are functionally distinct. Adenovirus E4-ORF3 protein expression alters the structure of the PML-NBs and interferon increases the number of PML-NBs and neither has any eect on PLZF NBs. The localization of PLZF/RARa is dierent to that of PLZF and RARa. The nuclear distribution pattern of PLZF/ RARa is one of hundreds of small dots (microspeckles) less than 0.1 micron. Expression of PLZF/RARa did not provoke disruption of the PML-NBs. Co-expression of PML/RARa and PLZF/RARa in U937 cells revealed apparent colocalization. Overall the results suggest that the PML-and PLZF-NBs are distinct functional nuclear domains, but that they may share common regulatory pathways and/or targeting sequences, as revealed by the common localization of their corresponding fusion proteins.
Introduction
Acute promyelocytic leukaemia (APL) is characterized by translocations that always involve chromosome 17, with the breakpoint in the locus that codes for the retinoic acid receptor a(RARa) and one of two partner chromosome: 15 and 11, with the breakpoints in the PML and PLZF loci respectively (Grignani et al., 1994; Warrell et al., 1993) . In both cases the anomalous translocation product is a fusion gene encoding, respectively, the PML/RARa and the PLZF/RARa fusion protein. The two fusion proteins retain the same portion of RARa, including the DNAbinding and ligand-binding domains (Chen et al., 1993; de TheÂ et al., 1991; Kakizuka et al., 1991; Kastner et al., 1992; Pandol® et al., 1992; Perez et al., 1993) . Less frequent APL-associated translocations are the t(5;17) and t(11;17) which also involve the RARa locus and the NPM and NuMA loci, respectively (Redner et al., 1996; Wells et al., 1997) .
PML and PLZF are nuclear proteins with distinct structural features. PML contains a tripartite motif composed of a RING ®nger, two B-Boxes and a coiled-coil region (Lovering et al., 1993; Freemont et al., 1991; Reddy et al., 1992) . The RING and two BBox regions are rich in cysteine and histidine residues, are capable of co-ordinating zinc in vitro and probably function as protein-protein interaction domains (Friedman et al., 1996; Wu et al., 1996) . The coiledcoil region is a dimerization interface that mediates the formation PML homodimers and PML heterodimers with PML/RARa (Kastner et al., 1992) . Instead, PLZF contains nine zinc ®ngers and a region with proteinprotein interaction function nominated POZ (Chen et al., 1993; Bardwell et al., 1994) .
There is much experimental evidence to support a leukaemogenetic role for the PML/RARa fusion protein: infection of chicken bone marrow with a retrovirus expressing PML/RARa induces leukaemia (Altabef et al., 1996) ; PML/RARa transgenic mice develop dierentiation anomalies in the myeloid compartment and, in a variable percentage, a true leukaemia with promyelocytic phenotype (Grisolano et al., 1997; Brown et al., 1997; He et al., 1997) ; the expression of PML/RARa in hematopoietic precursor cell lines increases survival and blocks terminal dierentiation induced by physiological stimuli (Grignani et al., 1993; Rogaia et al., 1995) . The few data available on PLZF/RARa suggest that it is also involved in leukaemogenesis. Like PML/RARa, expression of PLZF/RARa in hematopoietic precursor cell lines increases survival (unpublished) and induces block of terminal dierentiation (Ruthardt et al., 1997) .
Many studies have been carried out on PML/RARa to establish which fusion protein regions are relevant for its biologic activity. PML/RARa retains a large part of the PML protein, including the tripartite motif . Analysis of numerous PML/ RARa mutants has shown that the fusion of PML and RARa sequences is absolutely essential for the eect PML/RARa exerts on dierentiation and survival and that, within the context of the fusion protein, the PML coiled-coil and RARa DNA-binding region are indispensable (Grignani et al., 1996) . PML has growth-suppression activity and its alteration in the fusion protein may contribute to the biologic activity of PML/RARa on survival Mu et al., 1994) . Preliminary studies on PLZF/RARa indicate that the role of the PLZF sequence of the fusion protein is also crucial for the biologic activity of PLZF/RARa (Dong et al., 1996; Ruthardt et al., 1997) .
Overall these results suggest that the PML or PLZF and RARa sequences make similar contributions to the biologic activities of PML/RARa or PLZF/RARa. Considering that the two APL-speci®c fusion proteins have similar biologic activities, PML and PLZF may well share structural and/or functional characteristics. PML is localized to speci®c matrix-associated subdomains called nuclear bodies (PML-NB), also known as POD (PML oncogenic domains), ND10 (nuclear domain 10) or Kr bodies (Dyck et al., 1994; Everett et al., 1994; Koken et al., 1994; Weis et al., 1994; Flenghi et al., 1995) . Several proteins have been identi®ed that co-localize with PML within NBs, such as the SP100 protein, originally identi®ed as an autoantigen in patients with primary biliary cirrhosis (Szostecki et al., 1990) ; the PIC-1 PML interacting protein (Boddy et al., 1996) ; the retinoblastoma protein and Int-6 (Desbois et al., 1996) . The PML-NBs are thought to be critical targets during viral infection. In fact, a drastic redistribution of the PML-NBs into ®brous structures has been shown to occur during infection by DNA viruses such as herpes simplex and adenoviruses (Carvalho et al., 1995; Doucas et al., 1996; Everett et al., 1994; Puvion-Dutilleul et al., 1995) together with an increase in size and number after treatment of cells with interferon (IFN) (ChelbiAlix et al., 1995; Lavau et al., 1995; Stadler et al., 1995) . PLZF has also been reported to localize in nuclear regions that are morphologically similar to the PML-NBs (Reid et al., 1995) . In this paper we investigated the topographical relations between PML-NBs and PLZF-NBs in the KG1 myeloid precursor cell line, the eects of adenoviral protein expression and IFN treatment on the PLZF-NBs and the localization of the PLZF/RARa protein.
Results

PML and PLZF localize to adjacent NBs
To analyse the localization of PLZF proteins an anti-PLZF polyclonal antibody (see Materials and methods) was generated. Antibody speci®city was established by Western blot analysis of lysates from Cos-1 cells transiently transfected with an SV-40 origin-containing PLZF expression vector (pMT2 vector, see Materials and methods) and U937 cells transfected with an expression vector containing PLZF under the control of the ZnSO 4 (Zn) inducible metallothionine (MT-1) promoter (pGMTSVneo expression vector, see Materials and methods). The anti-PLZF antibody speci®cally recognized a polypeptide of the expected size (74 kDa) in lysates from Cos-1 cells transfected with the PLZF expression vector and the Zn-induced U937 B43 cells (Figure 1a) . No anti-PLZF signal was obtained in U937 cells prior to Zn induction, indicating that U937 cells do not express detectable PLZF polypeptides (Figure 1a) . The 74 kDa polypeptide detected by the anti-PLZF polyclonal antibody in Cos-1 transfected and Zn-induced U937 cells comigrated with a similarly sized polypetide in the myeloid leukemic KG1 cells (Figure 1a) , previously reported to express PLZF transcripts (Chen et al., 1993) . The anti-PLZF antibody did not cross react with PML in Western blotting of Cos-1 cells transfected with PML expression vectors (data not shown).
The anti-PLZF antibody was used to analyse PLZF expressing B43 U937 cells by indirect immunofluorescence experiments. Consistent with the Western blotting results, there was no staining prior to Zn induction (data not shown). However, a strong punctate staining pattern (approximately 5 ± 10 nuclear dots per cell; PLZF-NBs) was observed in cells induced to express the PLZF protein by Zn treatment (red¯uorochrome in Figure 2a ). This anti-PLZF staining is consistent with that reported by others (Reid et al., 1995) . As the PLZF localization pattern was very similar to that of wild-type PML, double staining experiments were performed on the PLZFexpressing cells using the PG-M3 anti-PML monoclonal antibody (Flenghi et al., 1995) and the anti-PLZF polyclonal serum. The anti-PML staining of Zninduced U937 PLZF B43 cells revealed 5 ± 10 nuclear dots per cell, consistent with the reported PML localization pattern (Daniel et al., 1993; Flenghi et al., 1995) (green¯uorochrome in Figure 2b ). Superimposition of the anti-PML and anti-PLZF stainings disclosed that a fraction (2 ± 3 dots per cell) of the PML-and PLZF-NBs co-localized (Figure 2c) .
The relationships between PML-NBs and PLZFNBs were then investigated in nontransfected cells. KG1 cells that express both PML and PLZF transcripts Chen et al., 1993) were analysed. Staining of KG1 cells with anti-PLZF (Figure 3a ; red¯uorochrome) and anti-PML ( Figure  3b ; green¯uorochrome) antibodies revealed, respectively, 14+2 and 19+3 dots per cell. The morphology of the NBs was similar to that seen in U937 cells transfected with PLZF. Superimposition of anti-PML and anti-PLZF staining disclosed, as in U937 cells, partial co-localization of PML-NBs and PLZF-NBs (about 4 ± 5 per cell) ( Figure 3c ). In KG1 cells, the anti-PLZF antibody revealed a weak ®brogranular pattern throughout the nucleoplasm and a weak cytoplasmic staining; further experiments are required to establish the speci®city of these anti-PLZF patterns of staining.
It will be noted that there is partial super imposition of anti-PML (green) and anti-PLZF (red) antibody stainings in some PML-PLZF co-localization images in both U937 (Figure 2c ) and KG1 (Figure 3c left of Figure 4 . Many PLZF-NBs (red) and PML-NBs (green) appear to be separated. However, co-localization (yellow) is visible in about 30% of the PLZF-NBs. A 5x electron magni®cation of the inset area of each is shown on the right of Figure 4 (a' ± d') and demonstrates more clearly the apparent co-localization of PML and PLZF. Within co-localizing NBs, it is evident that PML and PLZF coexist in areas where the stainings are superimposed, as well as in areas in which they clearly do not overlap. The results are the same when the confocal sections of the same regions are electronically rotated (908) and the image reconstructed on the vertical axis (see the low right panel of Figure 4 for a z-axis projection of a' ± d' slices). All these data lead to the conclusion that PML-NBs and PLZF-NBs are topographically distinct structures and that approximately 30% of them establish topographical contiguity.
PML and PLZF do not form soluble complexes in vivo
The apparent physical contact between PML-and PLZF-NBs, raised the question of whether PML and PLZF have the potential to form stable complexes in vivo. To this end, expression vectors for PML (PML3 isoform) and HA-tagged PLZF 
PML-NBs and PLZF-NBs are functionally distinct
The fact that a fraction of the PML and PLZF NBs revealed topographical relations prompted us to investigate whether PML and PLZF NBs share similar biological properties. Although the physiological function of the PML-NBs is unknown, some of their functional properties have been identi®ed. They are: (i) expression of the adenoviral E4-ORF3 protein leads to the disorganization of PML-NBs in ®liform nuclear structures where the E1A adenovirus protein accumulates (Carvalho et al., 1995; Doucas et al., 1996; Everett et al., 1994; Puvion-Dutilleul et al., 1995) ; (ii) IFN treatment increases the size and number of PML-NBs Lavau et al., 1995; Stadler et al., 1995) . For these reasons, we investigated whether some or all the PLZF-NBs behaved like the PML-NBs in the presence of ectopically expressed E4-ORF3 and in cells treated with IFN. KG1 cells were electroporated with an E4-ORF3 expression vector and stained with anti-PLZF and anti-PML antibodies. PLZF was not abnormally localized in any cell. Anti-PML staining, however, revealed cells with dramatically disorganized PMLNBs that form ®lamentous structures in the nucleus (see green anti-PML staining of KG1 cells in Figure  5 ). Superimposition of anti-PML and anti-PLZF staining provides clear evidence for the integrity of PLZF NBs (red staining) in cells in which E4-ORF3 expression has caused alterations of the PML-NBs ( Figure 5) .
We later analysed PML-NBs and PLZF-NBs in IFN-treated cells. KG1 cells were treated with 1000 U ml 71 IFNa and stained with anti-PML and anti-PLZF antibodies. The treatment induced an increase in the number and labeling intensity of PML-NBs, but had no eect on PLZF-NBs ( Figure  6 ). Moreover, when the anti-PML and anti-PLZF stainings were superimposed, there were no appreciable modi®cations in the PML-PLZF co-localization pattern ( Figure 6 ).
It would, therefore, seem that unlike PML-NBs, PLZF-NBs are unaected by either E4-ORF3 expression or IFN treatment and this suggests they have distinct functions. PML/RARa and PLZF/RARa fusion proteins colocalize within common microspeckled nuclear structures
The localization of the PML/RARa fusion protein is dierent to that of PML and RARa. PML, as mentioned, is localized in NBs and the RARa protein distributed diusely in the nucleus (Rochette-Egly et al., 1991) whereas the PML/RARa nuclear localization pattern is one of hundreds of tiny dots about less than 0.1 microns in diameter (microspeckles) (Dyck et al., 1994) . Such anomalous localization is considered relevant to the biological activity of the fusion protein: for example, by analysing many PML/RARa mutants, we have provided evidence that the eect of PML/RARa on cell survival depends on its localization in microspeckles . As the integrity of the PML component of the fusion proteins is indispensable for PML/RARa localization within microspeckles, we analysed the cellular localization of PLZF/RARa. To test the localization of the PLZF/RARa protein, PLZF/RARa cDNA was cloned under the control of the Zn-inducible MT-1 promoter and electroporated into U937 cells. One of the resulting PLZF/RARaexpressing U937 clones (clone B412 in Figure 1c ) was analysed by indirect immuno¯uorescence using the anti-PLZF polyclonal antibody. After Zn-induction of PLZF±RARa expression, the anti-PLZF antibody gave a strong micropunctate pattern characterized by abundant dots that were signi®cantly smaller than the PLZF-NBs (diameter less than 0.1 microns) ( Figure  7a ). This PLZF/RARa nuclear pattern was very similar to the reported microspeckled localization of PML/ RARa in APL blasts (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) . To investigate whether the microspeckled localization of PLZF/RARa re¯ected the disruption of the PML-NBs by PLZF/RARa, B412 cells were stained with the PG-M3 anti-PML monoclonal antibody. As shown in Figure 7b , the PG-M3 antibody gave a punctate staining pattern, consistent with the typical PML localization pattern of U937 cells. The PLZF/RARa microspeckles and the endogenous PML NBs did not apparently colocalize (Figure 7c) .
The topographic relation of the PML/RARa and PLZF/RARa microspeckles was investigated by coexpressing PML/RARa and PLZF/RARa in U937 cells (clone B14; see Figure 1c (d) and (e), respectively, and overlapped electronically
Discussion
Our immuno¯uorescence studies revealed that a characteristic feature of the PLZF expression pattern was the presence of nuclear bodies of about 0.3 ± 0.5 microns (approximately 14 per cell in the in KG1 myeloid leukaemia cell line) that were morphologically indistinguishable from those described for PML. For analogy with PML-NBs they were termed PLZF-NBs. PML and PLZF localization studies in cells that expressed both proteins showed that although the majority of PML-NBs and PLZF-NBs are topographically distinct, approximately 30% appear to co-localize. However, more detailed confocal microscope studies revealed that the co-localization was only apparent. The structures of the PLZF-NBs and PML-NBs were apparently maintained intact and they overlapped for variable tracts of their surface forming adjacent structures. We cannot, however, rule out that the confocal images re¯ect a tight spatial topography without, however, contacts between the PML-and PLZF-NBs, since the resolution between subsequent focal planes in the confocal microscope is barely above the size of the NBs (0.3 ± 0.5 microns). This picture of PML-and PLZF-NBs is not the ®rst example of a tight spatial relationship between nuclear domains. Two other nuclear bodies, the coiled and cleavage bodies, are often found extremely close to one another and even overlapping (Schul et al., 1996) . Coiled bodies contain high concentration of splicing factors, while the cleavage bodies contain two RNA 3' cleavage factors (CPSF and CstF), suggesting that these domains play some role in the processing of premRNA. As the level of transcription aects the degree of overlap between these nuclear domains, their tight spatial relation may well have functional signi®cance. PML-NBs are often adjacent to the pair of coiled and cleavage bodies, even if never truly overlapping (Schul et al., 1996) . Transcription levels do not aect the spatial disposition of PML-NBs and the functional signi®cance of this further spatial relationship remains unknown. No spatial relation was found between coiled bodies and PLZF-NBs (our unpublished results).
The functional signi®cance of the spatial relationship between PML-and PLZF-NBs is also unknown, due in part to lack of information on the physiologic function of PML and PLZF. A number of experimental evidences implicate PML and PML-NBs in the negative regulation of growth, since: (i) overexpression of PML induces growth suppression in vitro (Mu et al., 1994; Liu et al., 1995) ; (ii) PML is mainly expressed in resting cells (Flenghi et al., 1995) ; (iii) the PML-NB structure is destroyed during adenovirus infection due to the eect of the E4-ORF3 adenovirus protein (Carvalho et al., 1995; Doucas et al., 1996; Everett et al., 1994; Puvion-Dutilleul et al., 1995) ; (iv) PML is transcriptionally induced by the antiviral and antiproliferative agent IFN Lavau et al., 1995; Stadler et al., 1995) . Very little has been learnt about the function of PLZF, except that it is downregulated during terminal dierentiation of myeloid cells (Reid et al., 1995; Chen et al., 1993) . Our investigation now shows that PML-NBs and PLZF-NBs, although tightly related topographically, have distinct functional properties; PLZF-NBs are not aected by adenovirus E4-ORF3 expression and interferon. PLZF contains numerous zinc ®ngers and preliminary results suggest that some of these have DNA-binding activity and that PLZF is a transcription factor (Sitterlin et al., 1997) . PML contains no DNAbinding activity, but is involved in the regulation of many promoters; both cellular and viral (Mu et al., 1994; Guiochon-Mantel et al., 1995) . It could, therefore, be hypothesized, that the topographical connection that some PML-and PLZF-NBs make is an indication that PML exerts a regulatory role on PLZF transcriptional activity. The distribution of the PLZF NBs as well as the spatial relation between the PMLand PLZF-NBs does not appear to change during cell cycle (unpublished observation).
At present we do not know whether the partial overlapping of PML-and PLZF-NBs means there is physical interaction between the two proteins. The results of our investigation to answer the question of whether PML and PLZF form stable complexes suggest that the quantity of PML-PLZF stable complexes in vivo is negligible. A consistent fraction of PML is associated with the nuclear matrix and so insoluble; the NBs themselves are associated with the matrix . Therefore, stable PML-PLZF complexes associated with the matrix might be formed and would not be revealable by co-immunoprecipitation experiments.
We also demonstrated that the PLZF/RARa fusion protein is distributed in the nucleus in the form of microspeckles about less than 0.1 microns in diameter, that this localization is identical to that of PML/RARa and that PLZF/RARa expression does not disrupt the PML-NBs. As we have already shown that the microspeckled localization of PML/RARa depends on the integrity of the PML portion , the apparent identical localization of PML/RARa and PLZF/RARa suggest that the PLZF sequence retained in the corresponding fusion protein could have properties of targeting to speci®c nuclear domains in common with PML. Finally, the facts that the PML-NBs are intact in the PLZF/RARa expressing cells and, as recently reported, in the NuMA-RARa expressing APL blasts (Wells et al., 1997) , suggest that disruption of PML nuclear bodies is not a ®nal common pathway during the promyelocytic leukaemogenesis.
In conclusion, we have reported a novel nuclear domain, the PLZF-NB. This domain is immunologically identi®ed by anti-PLZF antibodies and is morphologically similar to the previously reported PML-NBs, coiled bodies and cleavage bodies. Topographic and functional relations exist between coiled bodies and cleavage bodies; while the PML-bodies establish contacts with the coiled bodies and the PLZFbodies. These network of interactions among dierent nuclear domains might re¯ect a hierarchy of nuclear compartments that contribute to the regulation of nuclear functions.
Materials and methods
PLZF, PLZF/RARa, PML/RARa and E4-ORF3 expression vectors
PLZF cDNA clones were isolated from a cDNA library of the KG1 myeloid leukaemia cells (Clontech, Palo Alto, CA) by using a DNA probe representative of the human PLZF POZ domain, according to standard screening protocols (Sambrook et al., 1989) . Out of eight isolated cDNAs one contained the full-length ORF of PLZF (clone 4B). It was 61 bp longer at the 5' end than to the reported PLZF B cDNA (Ruthardt et al., 1997) . The PLZF/RARa cDNA was reconstructed by PCR from wild-type PLZF and RARa cDNAs, as reported elsewhere (Ruthardt et al., 1997) . The PLZF and PLZF/RARa cDNAs were subcloned into the pGMTSVneo Zn-inducible expression vector (Grignani et al., 1993) and in the Adenovirus based pMT2 expression vector (Sambrook et al., 1989) . The PML/RARa expression vector is described elsewhere (Grignani et al., 1993) . The E4-ORF3 expression vector (pCMV-ORF3) was a kind gift from GoÈ ran AkusjaÈ rvi (O È hman et al., 1993) .
Preparation of anti-PLZF antibodies
The PLZF ORF was cloned into the bacterial expression plasmid pGEX-2T after PCR based creation of an in-frame BamHI site in correspondence of the ®rst ATG of PLZF. Bacterial cultures expressing pGEX vectors were grown in LB containing 50 mg/ml ampicillin, induced with 1 mM IPTG for 3 ± 6 h, and the induced bacteria were lysed by sonication in 1% TritonX-100. The GST-PLZF fusion protein was puri®ed using glutathione-agarose and eluted using 15 mM glutathione. Anti PLZF antibodies were prepared by immunising New Zealand white rabbits with the puri®ed GST-PLZF fusion protein.
Cell culture, transfection and Western blotting U937 cells were maintained in RPMI 1640 medium supplemented with 10% foetal calf serum. After electroporation the cells were selected in G418 and subcloned under limiting dilution conditions. Expression of the exogenous protein was evaluated by Western blotting after 6 ± 12 h induction with 100 mM ZnSO 4 , using an anti RARa-F (gift from P Chambon; Rochette-Egly et al., 1991) or the anti-PLZF antibodies, according to established procedures (Sambrook et al., 1989) . COS-1 cells were transiently transfected with DEAE-Dextran according to established procedures with a pMT2 expression vector for PLZF/RARa (Sambrook et al., 1989) . After 24 ± 36 h the expression of exogenous protein was tested by Western using the anti-RARa or the anti-PLZF antibody.
Coimmunoprecipitation experiments
Cos-1 cells co-transfected with 10 mg of PML and PLZF expression vectors were used to assess the formation of PML-PLZF complexes in vitro. Transiently transfected Cos-1 cells were washed twice with PBS and collected in E1A buer (HEPES 50 mM, NaCl 250 mM, EDTA 5 mM, DTT 1 mM, NP40 0.1%, PMSF (Sigma) 1 mM, leupeptin (Sigma) 1 mg/ml, aprotinin (Sigma) 1 mg/ml). The cell suspension was brie¯y sonicated and the lysates clari®ed by centrifugation. Lysates were pre-cleared by incubation for 1 h with protein A sepharose (Pharmacia). Immunoprecipitation was obtained by adding to the pre-cleared lysate protein A Sepharose (Pharmacia) and the relevant serum. Sepharose beads were washed four times in NET 1X buer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% NP40, 0.25% gelatin, 0.02% Na azide) and resuspended in SDS sample buer. Immunoprecipitates were Western blotted with the indicated antisera by the ECL method.
Immuno¯uorescence staining
Cells were cytocentrifuged and ®xed in methanol at room temperature for 5 min followed by acetone at 7208C for 2 min. PML staining was performed with the PGM3 monoclonal antibody (Flenghi et al., 1995) . PLZF staining was performed with the above mentioned polyclonal serum. After extensive washes in PBS cells were stained with FITC-, Texas-red-or TRITC-conjugated+ antimouse or anti-rabbit Ig antibodies (Southern Biotechnology Associates, Birmingham, AL). Microscopic analysis was performed on an Olympus BX-60¯uorescence microscopy equipped with a chilled 3CCD color camera (C5810, Hamamatsu Photonics, Japan). Images were captured with a 24 bit board (Image Grabber 24, Neotech, London, UK) on a 8100/80 Power Macintosh computer (Apple, Cupertino, USA). Distinct cubes for FITC (excitation ®lter 470 ± 490, dichroic mirror 505, barrier ®lter 515 ± 550 nm) and Texas-red or TRITC (excitation ®lter 510 ± 550, dichroic mirror 570, barrier ®lter LP590 nm) were used and the images were either directly stored or merged by the C5810 3CCD control unit. For confocal analysis cells were ®xed in solution with 3.7% paraformaldehyde in CSK (10 mM Pipes, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 2 mM EDTA) for 30' RT and permeated with 0.1% TritonX 100 for 5' RT. The staining was performed in solution as described above and thereafter cells were let adhere 30' at 48C on a polilysine coated coverslip. Cells were examined using an Olympus IMT-2 microscope equipped with an MRC-1024 laser scan confocal system (BioRad) using the 488 and 568 nm excitation lines from an argon/kripton laser. Green and red emissions were simultaneously recorded and processed with the LaserSharp 1024 software (BioRad) on a Compaq Prosignia 500 personal computer.
